Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MPN Advances Day 2019 | Atypical MPNs: focus on CNL and CEL

Andreas Reiter • 15 Nov 2019
MPN Advances Day 2019
Leukemia Myeloproliferative Neoplasms

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, gives an overview of the atypical myeloproliferative neoplasms (MPNs), with a focus on chronic neutrophilic leukemia (CNL) and chronic eosinophilic leukemia (CEL). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

More from Andreas Reiter

1:57
Challenges in myelofibrosis management
Andreas Reiter • 15 Nov 2019
2:15
MARS: mutation-adjusted risk score for advanced systemic mastocytosis
Andreas Reiter • 15 Nov 2019

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals